What Happened?
Atlanta, GA-based Antios-Therapeutics Appointed Greg Mayes as President and Chief Executive Officer
About the Company
Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.
About the Person
Greg Mayes is President and Chief Executive Officer at Antios Therapeutics. Previously, Greg held various senior HR leadership roles in the industry.
Info Source
News
Short Profile